Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

Details for Australian Patent Application No. 2008323811 (hide)

Owner Neogenix Oncology, Inc.

Inventors Kantor, Judith A.; Bristol, J. Andrew

Agent Spruson & Ferguson

Pub. Number AU-A-2008323811

PCT Pub. Number WO2009/062050

Priority 60/996,255 08.11.07 US

Filing date 7 November 2008

Wipo publication date 14 May 2009

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C12N 5/07 (2010.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Animal cells or tissues

C12N 15/00 (2006.01) Mutation or genetic engineering

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

18 March 2010 PCT application entered the National Phase

  PCT publication WO2009/062050 Priority application(s): WO2009/062050

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008323815-Uses of anti-CD40 antibodies

2008323792-Surgical console information display system and method